Association of human leukocyte antigen-DRB1 alleles with disease susceptibility and severity of aplastic anemia in Korean patients

Human Immunology

Volumn 69, Issue 6, 2008, Pages 354-359

  Song, Eun Young ^a,b   Park, Soyun ^b   Lee, Dong Soon ^b   Cho, Han Ik ^b   Park, Myoung Hee ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Aplastic anemia; HLA DRB1; Korean; Severity; Susceptibility

Indexed keywords

HLA DR ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLELE; APLASTIC ANEMIA; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; INFANT; KOREA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; INFANT; KOREA; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 50949084932     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.04.009     Document Type: Article

References (25)

1. Risitano A.M., Maciejewski J.P., Green S., Plasilova M., Zeng W., and Young N.S. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR β-CDR3 sequencing. Lancet 364 (2004) 355-364
2. Young N.S., Calado R.T., and Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108 (2006) 2509-2519
3. Nimer S.D., Ireland P., Meshkinpour A., and Frane M. An increased HLA DR2 frequency is seen in aplastic anemia patients. Blood 84 (1994) 923-927
4. Nakao S., Takamatsu H., Chuhjo T., Ueda M., Shiobara S., Matsuda T., et al. Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporin dependent aplastic anemia. Blood 84 (1994) 4257-4261
5. İhan O., Beksaç M., Arslan O{double acute}., O{double acute}zcan M., Koç H., Akan H., et al. HLA DR2: a predictive marker in response to cyclosporin therapy in aplastic anemia. Int J Hematol 66 (1997) 291-295
6. Shao W., Tian D., Liu C., Sun X., and Zhang X. Aplastic anemia is associated with HLA-DRB1*1501 in northern Han Chinese. Int J Hematol 71 (2000) 350-352
7. Kapustin S.I., Popova T.I., Lyshchov A.A., Imyanitov E.N., Blinov M.N., and Abdulkadyrov K.M. HLA-DR4-Ala74β is associated with risk and poor outcome of severe aplastic anemia. Ann Hematol 80 (2001) 66-71
8. Maciejewski J.P., Follmann D., Nakamura R., Saunthararajah Y., Rivera C.E., Simonis T., et al. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Blood 98 (2001) 3513-3519
9. Oguz F.S., Yalman N., Diler A.S., Oguz R., Anak S., and Dorak M.T. HLA-DRB1*15 and pediatric aplastic anemia. Haematologica 87 (2002) 772-774
10. Saunthararajah Y., Nakamura R., Nam J.M., Robyn J., Loberiza F., Maciejewski J.P., et al. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood 100 (2002) 1570-1574
11. Usman M., Adil S.N., Moatter T., Bilwani F., Arian S., and Khurshid M. Increased expression of HLA DR2 in acquired aplastic anemia and its impact on response to immunosuppressive therapy. J Pak Med Assoc 54 (2004) 251-254
12. Sugimori C., Yamazaki H., Feng X., Mochizuki K., Kondo Y., Takami A., et al. Roles of DRB1*1501 and DRB1*1502 in the pathogenesis of aplastic anemia. Exp Hematol 35 (2007) 13-20
13. Camitta B.M., Thomas E.D., Nathan D.G., Gale R.P., Kopecky K.J., Rappeport J.M., et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53 (1979) 504-514
14. Marsh J.C., Ball S.E., Darbyshire P., Gordon-Smith E.C., Keidan A.J., Martin A., et al., British Committee for Standards in Haematology. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 123 (2003) 782-801
15. Song E.Y., Park H., Roh E.Y., and Park M.H. HLA-DRB1 and -DRB3 allele frequencies and haplotypic associations in Koreans. Hum Immunol 65 (2004) 270-276
16. Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study. Blood 70 (1987) 1718-1721
17. Vince A., Poljak M., and Seme K. DNA extraction from archival Giemsa-stained bone-marrow slides: comparison of six rapid methods. Br J Haematol 101 (1998) 349-351
18. Bannai M., Tokunaga K., Lin L., Kuwata S., Mazda T., Amaki I., et al. Discrimination of human HLA-DRB1 alleles by PCR-SSCP (single-strand conformation polymorphism) method. Eur J Immunogenet 21 (1994) 1-9
19. Kim K.Y., Cho H.S., Shin J.S., Lyu C.H., Yang C.H., Park S.H., et al. Response to immunosuppressive therapy and an HLA-DR allele in children with aplastic anemia. Korean J Hematol 34 (1999) 36-42
20. Kook H., Hwang T.J., Seo J.J., Ghim T.T., Moon H.N., Lee Y.H., et al. The frequency of HLA alleles in Korean children with aplastic anemia and correlation with the response to immunosuppressive treatment. Korean J Pediatr Hematol Oncol 10 (2003) 177-188
21. Fu{double acute}hrer M., Durner J., Bru{double acute}nnler G., Götte H., Deppner C., Bender-Go{double acute}tze C., et al. HLA association is different in children and adults with severe acquired aplastic anemia. Pediatr Blood Cancer 48 (2007) 186-191
22. Singh R., Kaul R., Kaul A., and Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 13 (2007) 1770-1787
23. Apple R.J., Erlich H.A., Klitz W., Manos M.M., Becker T.M., and Wheeler C.M. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 6 (1994) 157-162
24. Tang J., Penman-Aguilar A., Lobashevsky E., Allen S., Kaslow R.A., and Zambia-UAB HIV Research Project. HLA-DRB1 and -DQB1 alleles and haplotypes in Zambian couples and their associations with heterosexual transmission of HIV type 1. J Infect Dis 189 (2004) 1696-1704
25. Imanishi T., Akaza T., Kimura A., Tokunaga K., and Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K., Aizawa M., and Sasazuki T. (Eds). HLA 1991 Vol 1 (1992), Oxford University Press, New York